Patient Guide: A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 151 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06143891
Status: ACTIVE_NOT_RECRUITING
Condition: Chronic Graft Versus Host Disease
Phase: PHASE3

Where You Can Participate

This study is available at 151 locations across the country.

Top locations include:
  • • Little Rock, Arkansas
  • • Duarte, California
  • • San Francisco, California
  • • And 148 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. - Join Clinical Trial NCTNCT06143891

How to Join This Clinical Trial - NCTNCT06143891

Learn how to participate in this PHASE3 trial studying an investigational therapy for Chronic Graft Versus Host Disease. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Graft Versus Host Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Graft Versus Host Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06143891 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 151 locations. Find a study site near you:

Clinical Research Site

Little Rock, Arkansas 72205 - United States

Status: Contact for availability

Clinical Research Site

Duarte, California 91010 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94143 - United States

Status: Contact for availability

Clinical Research Site

Orlando, Florida 32803 - United States

Status: Contact for availability

Clinical Research Site

Decatur, Georgia 30030 - United States

Status: Contact for availability

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: Contact for availability

Clinical Research Site

Indianapolis, Indiana 46202 - United States

Status: Contact for availability

Clinical Research Site

Lexington, Kentucky 40536 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21287 - United States

Status: Contact for availability

Clinical Research Site

Boston, Massachusetts 02115 - United States

Status: Contact for availability

And 141 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Chronic Graft Versus Host Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships